94 related articles for article (PubMed ID: 8113840)
1. Vinorelbine as first-line chemotherapy for metastatic breast carcinoma.
Romero A; Rabinovich MG; Vallejo CT; Perez JE; Rodriguez R; Cuevas MA; Machiavelli M; Lacava JA; Langhi M; Romero Acuña L
J Clin Oncol; 1994 Feb; 12(2):336-41. PubMed ID: 8113840
[TBL] [Abstract][Full Text] [Related]
2. Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.
Gasparini G; Caffo O; Barni S; Frontini L; Testolin A; Guglielmi RB; Ambrosini G
J Clin Oncol; 1994 Oct; 12(10):2094-101. PubMed ID: 7931479
[TBL] [Abstract][Full Text] [Related]
3. Vinorelbine as neoadjuvant chemotherapy in advanced cervical carcinoma.
Lacava JA; Leone BA; Machiavelli M; Romero AO; Perez JE; Elem YL; Ferreyra R; Focaccia G; Suttora G; Salvadori MA; Cuevas MA; Acuña LR; Acuña JR; Langhi M; Amato S; Castaldi J; Arroyo A; Vallejo CT
J Clin Oncol; 1997 Feb; 15(2):604-9. PubMed ID: 9053483
[TBL] [Abstract][Full Text] [Related]
4. Vinorelbine and paclitaxel as first-line chemotherapy in metastatic breast cancer.
Romero Acuña L; Langhi M; Pérez J; Romero Acuña J; Machiavelli M; Lacava J; Vallejo C; Romero A; Fasce H; Ortiz E; Grasso S; Amato S; Rodríguez R; Barbieri M; Leone B
J Clin Oncol; 1999 Jan; 17(1):74-81. PubMed ID: 10458220
[TBL] [Abstract][Full Text] [Related]
5. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
Ray-Coquard I; Biron P; Bachelot T; Guastalla JP; Catimel G; Merrouche Y; Droz JP; Chauvin F; Blay JY
Cancer; 1998 Jan; 82(1):134-40. PubMed ID: 9428489
[TBL] [Abstract][Full Text] [Related]
6. Ifosfamide and mitoxantrone as first-line chemotherapy for metastatic breast cancer.
Perez JE; Machiavelli M; Leone BA; Romero A; Rabinovich MG; Vallejo CT; Bianco A; Lacava JA; Rodriguez R; Cuevas MA
J Clin Oncol; 1993 Mar; 11(3):461-6. PubMed ID: 8445421
[TBL] [Abstract][Full Text] [Related]
7. Ifosfamide and vinorelbine as first-line chemotherapy for metastatic breast cancer.
Leone BA; Vallejo CT; Romero AO; Perez JE; Cuevas MA; Lacava JA; Sabatini CL; Dominguez ME; Rodriguez R; Barbieri MR; Ortiz EH; Salvadori MA; Acuña LA; Acuña JM; Langhi MJ; Amato S; Machiavelli MR
J Clin Oncol; 1996 Nov; 14(11):2993-9. PubMed ID: 8918497
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy.
Fumoleau P; Delgado FM; Delozier T; Monnier A; Gil Delgado MA; Kerbrat P; Garcia-Giralt E; Keiling R; Namer M; Closon MT
J Clin Oncol; 1993 Jul; 11(7):1245-52. PubMed ID: 8315421
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group.
Conroy T; Etienne PL; Adenis A; Wagener DJ; Paillot B; François E; Bedenne L; Jacob JH; Seitz JF; Bleiberg H; Van Pottelsberghe C; Van Glabbeke M; Delgado FM; Merle S; Wils J
J Clin Oncol; 1996 Jan; 14(1):164-70. PubMed ID: 8558192
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of a combination of vinorelbine, cyclophosphamide and 5-fluorouracil in the treatment of advanced breast cancer.
Ardavanis A; Extra JM; Espié M; Cuvier C; Marty M
In Vivo; 1998; 12(5):559-62. PubMed ID: 9827368
[TBL] [Abstract][Full Text] [Related]
11. Phase I/II trial of continuous infusion vinorelbine for advanced breast cancer.
Toussaint C; Izzo J; Spielmann M; Merle S; May-Levin F; Armand JP; Lacombe D; Tursz T; Sunderland M; Chabot GG
J Clin Oncol; 1994 Oct; 12(10):2102-12. PubMed ID: 7931480
[TBL] [Abstract][Full Text] [Related]
12. Vinorelbine-induced neurotoxicity in patients with advanced breast cancer pretreated with paclitaxel--a phase II study.
Fazeny B; Zifko U; Meryn S; Huber H; Grisold W; Dittrich C
Cancer Chemother Pharmacol; 1996; 39(1-2):150-6. PubMed ID: 8995513
[TBL] [Abstract][Full Text] [Related]
13. Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer.
Livingston RB; Ellis GK; Gralow JR; Williams MA; White R; McGuirt C; Adamkiewicz BB; Long CA
J Clin Oncol; 1997 Apr; 15(4):1395-400. PubMed ID: 9193331
[TBL] [Abstract][Full Text] [Related]
14. [Treatment outcomes with vinorelbine for metastatic breast cancer patients previously treated with both doxorubicin and docetaxel].
Tashiro H; Sonoda K; Ohshiro T; Ohta M; Yamamura S; Ishikawa T; Itasaka H; Matsusaka T; Kume K
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1397-401. PubMed ID: 11681247
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of vinorelbine with protracted fluorouracil infusion as a second- or third-line approach for advanced breast cancer patients previously treated with anthracyclines.
Berruti A; Sperone P; Bottini A; Gorzegno G; Lorusso V; Brunelli A; Botta M; Tampellini M; Donadio M; Mancarella S; De Lena M; Alquati P; Dogliotti L
J Clin Oncol; 2000 Oct; 18(19):3370-7. PubMed ID: 11013277
[TBL] [Abstract][Full Text] [Related]
16. Full dose paclitaxel plus vinorelbine as salvage chemotherapy in anthracycline-resistant advanced breast cancer: a phase II study.
Polyzos A; Tsavaris N; Kosmas C; Gogas H; Toufexi H; Kosmidis C; Markopoulos C; Giannopoulos A; Papadopoulos O; Stamatiadis D; Kouraklis G
J Chemother; 2003 Dec; 15(6):607-12. PubMed ID: 14998089
[TBL] [Abstract][Full Text] [Related]
17. Phase III comparative study of vinorelbine combined with doxorubicin versus doxorubicin alone in disseminated metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8.
Norris B; Pritchard KI; James K; Myles J; Bennett K; Marlin S; Skillings J; Findlay B; Vandenberg T; Goss P; Latreille J; Rudinskas L; Lofters W; Trudeau M; Osoba D; Rodgers A
J Clin Oncol; 2000 Jun; 18(12):2385-94. PubMed ID: 10856098
[TBL] [Abstract][Full Text] [Related]
18. Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trial.
De Maio E; Pacilio C; Gravina A; Morabito A; Di Rella F; Labonia V; Landi G; Nuzzo F; Rossi E; Silvestro P; Botti G; Di Bonito M; Curcio MP; Formichelli F; La Vecchia F; Staiano M; Maurea N; D'Aiuto G; D'Aiuto M; Thomas R; Signoriello G; Perrone F; de Matteis A
BMC Cancer; 2007 Mar; 7():50. PubMed ID: 17374151
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancer.
Spielmann M; Dorval T; Turpin F; Antoine E; Jouve M; Maylevin F; Lacombe D; Rouesse J; Pouillart P; Tursz T
J Clin Oncol; 1994 Sep; 12(9):1764-70. PubMed ID: 8083698
[TBL] [Abstract][Full Text] [Related]
20. Vinorelbine and docetaxel as first-line chemotherapy in metastatic breast cancer.
Vassilomanolakis M; Koumakis G; Drufakou S; Aperis G; Demiri M; Barbounis V; Missitzis J; Efremidis AP
Cancer Chemother Pharmacol; 2003 Feb; 51(2):179-83. PubMed ID: 12647021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]